e-learning
resources
Munich 2014
Tuesday, 09.09.2014
New mechanisms in the pathogenesis of asthma and other lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association between body mass index (BMI) and markers of eosinophilic inflammation in asthma
R. Berair, V. Mistry, A. Singapuri, S. Gonem, C. Newby, S. Siddiqui, R. Kay, C. Brightling (Leicester, United Kingdom; Basel, Switzerland)
Source:
International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Session:
New mechanisms in the pathogenesis of asthma and other lung diseases
Session type:
Thematic Poster Session
Number:
3870
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Berair, V. Mistry, A. Singapuri, S. Gonem, C. Newby, S. Siddiqui, R. Kay, C. Brightling (Leicester, United Kingdom; Basel, Switzerland). Association between body mass index (BMI) and markers of eosinophilic inflammation in asthma. Eur Respir J 2014; 44: Suppl. 58, 3870
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Association between airway inflammation, airway remodelling and physiological changes in asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
MIP-1β is associated with eosinophilic airway inflammation
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
The airway microbiota is significantly altered in subjects with eosinophilic asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Airway remodeling and eosinophilic asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Effects of aerobic training on perivascular inflammation and on vascular activation in a model of asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Body mass index and adipose tissue within the airway wall
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Humoral immunity parameters in smoking and non-smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Airway inflammation in patients with different levels of asthma control
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Blood cytotoxic/pro-inflammatory mediators in severe asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Omalizumab prevents smooth muscle cell growth induced by asthmatic serum
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Body mass impacts distal airway function
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Influence of ADRβ2 gene polymorphism on the level of bronchial obstruction and body mass index in patients with bronchial asthma
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Association between cardio-ankle vascular index (CAVI) and chronic airway obstruction in asthma
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Discrimination of bronchial inflammatory phenotype of asthmatic patients by using the electronic nose
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Influence of body mass index on asthma severity and control: A cross-sectional study
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept